CardioKinetix Inc. Announces First Heart Failure Patients Treated in Asia with Minimally Invasive Structural Heart Device

Published: Aug 29, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif.--(BUSINESS WIRE)--CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced a new first with four patients successfully treated this week with the novel catheter-based Parachute® Ventricular Partitioning Device in Kuala Lumpur, Malaysia.

Help employers find you! Check out all the jobs and post your resume.

Back to news